EXOME

all the information, none of the junk | biotech • healthcare • life sciences

Hollis-Eden Now Harbor BioSciences

San Diego drug developer Hollis-Eden Pharmaceuticals says it has changed its name to Harbor BioSciences, nearly a year after the company fired Richard Hollis, the biotech’s namesake founder and CEO, for cause unknown. Harbor BioSciences also changed its ticker symbol to (NASDAQ: HRBR), saying that shares would begin trading under the new ticker today. The biotech says it is continuing to develop a new steroid analog that stimulates apoptosis, or programmed cell death, in hormone-dependent prostate tumors.

Trending on Xconomy

The Author

Bruce V. Bigelow is the editor of Xconomy San Diego. You can e-mail him at bbigelow@xconomy.com or call (619) 669-8788

By posting a comment, you agree to our terms and conditions.